<DOC>
	<DOC>NCT00096421</DOC>
	<brief_summary>The purpose of this study is to evaluate the impact of tight control of serum glucose levels with an intensive insulin treatment in patients hospitalized in an intensive care unit with medical and surgical patients.</brief_summary>
	<brief_title>Tight Glycemic Control in Critical Care Patients</brief_title>
	<detailed_description>Reduction of morbidity-mortality in critical care patients with tight glycemic control had been proven in surgical patients only. Study Hypothesis: In critical care patients, medical or surgical, a glucose serum level between 80 - 110 mg/dL means a lower mortality than patients with glucose levels of more than 110 mg/dL.</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>15 years of age or older, Probability of staying in critical care for more than 48 hours, Agreement with the informed consent. Pregnancy, Participating in other trials, Diabetic ketoacidosis or diabetic hyperosmolar state, Moribund Donotresuscitate orders, Reentry to the critical care unit of the same patient.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Critical illness</keyword>
	<keyword>Critical care</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Intensive care</keyword>
	<keyword>Intensive Care Units</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Intensive insulin therapy</keyword>
	<keyword>Conventional insulin therapy</keyword>
</DOC>